Tissue Distribution, Excretion and Pharmacokinetics of the Environmental Pollutant Dibenzo[def,p]chrysene in Mice.

Dibenzo[def,p]chrysene (DBP), a representative example of the class of polycyclic aromatic hydrocarbon (PAH), is known to induce tumors in multiple organ sites including the ovary, lung, mammary glands, and oral cavity in rodents. The goal of this study was to test the hypothesis that the levels of DBP and its metabolites that reach and retain the levels for an extended time in the target organs as well as the capacity of these organs to metabolize this carcinogen to active metabolites that can damage DNA may account for its tissue selective tumorigenicity. Therefore, we used the radiolabeled [(3)H] DBP to accurately assess the tissue distribution, excretion, and pharmacokinetics of this carcinogen. We also compared the levels of DBPDE-DNA adducts in a select target organ (ovary) and nontarget organs (kidney and liver) in mice treated orally with DBP. Our results showed that after 1 week, 91.40 ± 7.23% of the radioactivity was recovered in the feces; the corresponding value excreted in the urine was less than 2% after 1 week. After 24 h, the stomach had the highest radioactivity followed by the intestine and the liver; however, after 1 week, levels of the radioactivity in these organs were the lowest among tissues examined including the ovary and liver; the pharmacokinetic analysis of DBP was conducted using a one compartment open model. The level of (-)-anti-trans-DBPDE-dA in the ovaries (8.91 ± 0.08 adducts/10(7) dA) was significantly higher (p < 0.01) than the levels of adducts in kidneys (0.69 ± 0.09 adducts/10(7) dA) and livers (0.63 ± 0.11 adducts/10(7) dA). Collectively, the results of the tissue distribution and pharmacokinetic analysis may not fully support our hypothesis, but the capacity of the target organs vs nontarget organs to metabolize DBP to active intermediates that can damage DNA may account for its tissue selective tumorigenicity.

[1]  S. Amin,et al.  Simultaneous Detection of Deoxyadenosine and Deoxyguanosine Adducts in the Tongue and Other Oral Tissues of Mice Treated with Dibenzo[a,l]pyrene , 2014, Chemical research in toxicology.

[2]  K. Ahn,et al.  Mechanisms of oral carcinogenesis induced by dibenzo[a,l]pyrene: An environmental pollutant and a tobacco smoke constituent , 2013, International journal of cancer.

[3]  David E. Williams,et al.  Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  K. Ahn,et al.  Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: a potential new model for oral cancer , 2012, International journal of cancer.

[5]  S. Amin,et al.  Induction of ovarian cancer and DNA adducts by Dibenzo[a,l]pyrene in the mouse. , 2012, Chemical research in toxicology.

[6]  Richard A Corley,et al.  Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents. , 2011, Toxicology and applied pharmacology.

[7]  S. Amin,et al.  Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a,l]pyrene by HPLC-MS/MS. , 2011, Chemical research in toxicology.

[8]  T. Penning,et al.  Polycyclic Aromatic Hydrocarbons: Multiple Metabolic Pathways and the DNA Lesions Formed , 2010 .

[9]  K. Straif,et al.  Carcinogenicity of polycyclic aromatic hydrocarbons. , 2005, The Lancet. Oncology.

[10]  N. Kerkvliet,et al.  Dibenzo[a,l]pyrene induced DNA adduct formation in lung tissue in vivo. , 2005, Cancer letters.

[11]  H. Dienes,et al.  Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol. , 2004, Chemico-biological interactions.

[12]  S. Amin,et al.  A Highly Abbreviated Synthesis of Dibenzo[def,p]chrysene and Its 12-Methoxy Derivative, a Key Precursor for the Synthesis of the Proximate and Ultimate Carcinogens of Dibenzo[def,p]chrysene. , 2004, Journal of Organic Chemistry.

[13]  A. Luch,et al.  Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation. , 2002, Chemical research in toxicology.

[14]  C. Hansch,et al.  The relative toxicity of compounds in mainstream cigarette smoke condensate. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  S. Nesnow,et al.  Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. , 1997, Carcinogenesis.

[16]  S. Amin,et al.  Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene. , 1995, Carcinogenesis.

[17]  S. Amin,et al.  Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,l]pyrene. , 1995, Carcinogenesis.

[18]  N. H. Velthorst,et al.  Direct Determination of Dibenzo[a,l]pyrene in Crude Extracts of Environmental Samples by Laser-Excited Shpol'skii Spectroscopy , 1995 .

[19]  E. LaVoie,et al.  Exceptional tumor-initiating activity of 4-fluorobenzo[j]-fluoranthene on mouse skin: comparison with benzo[j]-fluoranthene, 10-fluoro-benzo[j]fluoranthene, benzo[a]pyrene, dibenzo[a,l]pyrene and 7,12-dimethylbenz[a]anthracene. , 1993, Cancer letters.

[20]  N. V. Ramakrishna,et al.  Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. , 1993, Carcinogenesis.

[21]  J. Chuang,et al.  Indoor air sampling and mutagenicity studies of emissions from unvented coal combustion. , 1987, Environmental science & technology.

[22]  H. Tong,et al.  Quantitation of polycyclic aromatic hydrocarbons in diesel exhaust particulate matter by high-performance liquid chromatography fractionation and high-resolution gas chromatography. , 1984, Analytical chemistry.

[23]  D. Phillips.  Fifty years of benzo(a)pyrene , 1983, Nature.

[24]  A. Conney,et al.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. , 1982, Cancer research.

[25]  S. Burchiel,et al.  Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. , 2010, IARC monographs on the evaluation of carcinogenic risks to humans.

[26]  Andreas Luch,et al.  On the impact of the molecule structure in chemical carcinogenesis. , 2009, EXS.

[27]  N. V. Ramakrishna,et al.  Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland. , 1991, Carcinogenesis.

[28]  J. Fisher,et al.  Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models. A two-compartment description. , 1991, Drug metabolism and disposition: the biological fate of chemicals.